Enrique Samper Rodriguez
Algemeen Directeur bij NIMGenetics Genómica y Medicina SL
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Javier Suela Rubio | M | - |
NIMGenetics Genómica y Medicina SL
NIMGenetics Genómica y Medicina SL Pharmaceuticals: MajorHealth Technology NIMGenetics Genómica y Medicina SL operates as a biomedical company. It specializes in the design and commercialization of products and services for clinical genetic diagnosis. The firm offers Nimfish, exonim, Trisonim, Karyonim, and Onconim products. The company was founded in 2008 and is headquartered in Madrid, Spain. | 16 jaar |
Sara Alvarez de Andres | M | - |
NIMGenetics Genómica y Medicina SL
NIMGenetics Genómica y Medicina SL Pharmaceuticals: MajorHealth Technology NIMGenetics Genómica y Medicina SL operates as a biomedical company. It specializes in the design and commercialization of products and services for clinical genetic diagnosis. The firm offers Nimfish, exonim, Trisonim, Karyonim, and Onconim products. The company was founded in 2008 and is headquartered in Madrid, Spain. | 16 jaar |
Goranka Tanackovic | M | - |
GENE PREDICTIS SA
GENE PREDICTIS SA Miscellaneous Commercial ServicesCommercial Services Part of NIMGenetics Genómica y Medicina SL, Gene Predictis SA engages in the development of diagnostic tools based on genetics that allow treatments for patients. The company is based in Lausanne, Switzerland. The Swiss company was founded in 2004. Goranka Tanackovic has been the CEO of the company since 2011. Gene Predictis was acquired by NIMGenetics Genómica y Medicina SL on February 13, 2023. | 13 jaar |
David de Martin | M | - |
GENE PREDICTIS SA
GENE PREDICTIS SA Miscellaneous Commercial ServicesCommercial Services Part of NIMGenetics Genómica y Medicina SL, Gene Predictis SA engages in the development of diagnostic tools based on genetics that allow treatments for patients. The company is based in Lausanne, Switzerland. The Swiss company was founded in 2004. Goranka Tanackovic has been the CEO of the company since 2011. Gene Predictis was acquired by NIMGenetics Genómica y Medicina SL on February 13, 2023. | 3 jaar |
Anne-Laure Meynier | F | 39 |
GENE PREDICTIS SA
GENE PREDICTIS SA Miscellaneous Commercial ServicesCommercial Services Part of NIMGenetics Genómica y Medicina SL, Gene Predictis SA engages in the development of diagnostic tools based on genetics that allow treatments for patients. The company is based in Lausanne, Switzerland. The Swiss company was founded in 2004. Goranka Tanackovic has been the CEO of the company since 2011. Gene Predictis was acquired by NIMGenetics Genómica y Medicina SL on February 13, 2023. | - |
Patrick Chalançon | M | - |
GENE PREDICTIS SA
GENE PREDICTIS SA Miscellaneous Commercial ServicesCommercial Services Part of NIMGenetics Genómica y Medicina SL, Gene Predictis SA engages in the development of diagnostic tools based on genetics that allow treatments for patients. The company is based in Lausanne, Switzerland. The Swiss company was founded in 2004. Goranka Tanackovic has been the CEO of the company since 2011. Gene Predictis was acquired by NIMGenetics Genómica y Medicina SL on February 13, 2023. | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Jose Luis Vallejo Pizarro | M | - |
NIMGenetics Genómica y Medicina SL
NIMGenetics Genómica y Medicina SL Pharmaceuticals: MajorHealth Technology NIMGenetics Genómica y Medicina SL operates as a biomedical company. It specializes in the design and commercialization of products and services for clinical genetic diagnosis. The firm offers Nimfish, exonim, Trisonim, Karyonim, and Onconim products. The company was founded in 2008 and is headquartered in Madrid, Spain. | 10 jaar |
Juan Cruz Cigudosa | M | - |
NIMGenetics Genómica y Medicina SL
NIMGenetics Genómica y Medicina SL Pharmaceuticals: MajorHealth Technology NIMGenetics Genómica y Medicina SL operates as a biomedical company. It specializes in the design and commercialization of products and services for clinical genetic diagnosis. The firm offers Nimfish, exonim, Trisonim, Karyonim, and Onconim products. The company was founded in 2008 and is headquartered in Madrid, Spain. | - |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Spanje | 4 | 50.00% |
Zwitserland | 4 | 50.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Enrique Samper Rodriguez
- Persoonlijk netwerk